Announced
Completed
Synopsis
AEA Investors-backed Verdesian, a developer of fertilizers and agrochemicals, completed the acquisition of Cytozyme, a biosimulator manufacturer. Financial terms were not disclosed. “For more than four decades, Cytozyme’s mission has been to help farmers achieve sustainable yields through innovative solutions. We firmly believe that Verdesian Life Sciences has the technology, capabilities, and the people to continue that mission in a way that is true to our ideals. Our two companies’ product mixes are incredibly complementary; this is a great day for growers everywhere," Eric Baughman, Cytozyme CEO.
Principals
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.